21.48
Schlusskurs vom Vortag:
$21.56
Offen:
$21.21
24-Stunden-Volumen:
469.09K
Relative Volume:
0.79
Marktkapitalisierung:
$962.70M
Einnahmen:
$206.22M
Nettoeinkommen (Verlust:
$-16.70M
KGV:
-55.65
EPS:
-0.386
Netto-Cashflow:
$-5.55M
1W Leistung:
+9.15%
1M Leistung:
+15.48%
6M Leistung:
+60.30%
1J Leistung:
+39.21%
Si Bone Inc Stock (SIBN) Company Profile
Firmenname
Si Bone Inc
Sektor
Branche
Telefon
(408) 207-0700
Adresse
471 EL CAMINO REAL, SUITE 101, SANTA CLARA, CA
Compare SIBN vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
SIBN
Si Bone Inc
|
21.48 | 962.70M | 206.22M | -16.70M | -5.55M | -0.386 |
|
ABT
Abbott Laboratories
|
103.70 | 179.44B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
95.41 | 122.04B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
SYK
Stryker Corp
|
307.15 | 117.81B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
45.69 | 66.22B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
89.07 | 51.34B | 6.30B | 1.07B | 1.09B | 1.8406 |
Si Bone Inc Stock (SIBN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-07-28 | Eingeleitet | UBS | Buy |
| 2026-01-27 | Eingeleitet | TD Cowen | Buy |
| 2024-08-06 | Bestätigt | Needham | Buy |
| 2024-03-28 | Eingeleitet | Piper Sandler | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-04-07 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-06-08 | Eingeleitet | Citigroup | Buy |
| 2021-03-09 | Bestätigt | Needham | Buy |
| 2020-12-16 | Bestätigt | Needham | Buy |
| 2020-08-04 | Bestätigt | Needham | Buy |
| 2020-06-16 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-05-05 | Bestätigt | Needham | Buy |
| 2020-02-19 | Eingeleitet | Needham | Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-12-18 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-11-12 | Eingeleitet | BofA/Merrill | Buy |
| 2018-11-12 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-11-12 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2018-11-12 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Si Bone Inc Aktie (SIBN) Neueste Nachrichten
Si-BONE CEO Laura Francis sells $762,012 in company stock By Investing.com - Investing.com Nigeria
Form 4 Si-Bone Inc: Laura Francis (Director, CEO) For: 12 October By Investing.com - Investing.com South Africa
Si-BONE CEO Laura Francis sells $762,012 in company stock By Investing.com - Investing.com Canada
Form 4 Si-Bone Inc: Laura Francis (Director, CEO) For: 12 October - Investing.com Nigeria
Si-BONE CEO Laura Francis sells $762,012 in company stock - Investing.com
Form 144 SI-BONE For: 13 October By Investing.com - Investing.com Nigeria
A Francis trust lists $736K in SI-BONE (SIBN) shares for sale through Morgan Stanley Smith Barney. - Stock Titan
Si-Bone director Jeffrey Dunn sells $369,400 in stock - Investing.com
Si-Bone director Jeffrey Dunn sells $369,400 in stock By Investing.com - Investing.com Canada
SI-BONE Insiders Sold US$4.2m Of Shares Suggesting Hesitancy - Moomoo
Form 4 Si-Bone Inc For: 11 October By Investing.com - Investing.com South Africa
Si-Bone COO & CFO Anshul Maheshwari sells $94,078 in company stock - Investing.com
Form 4 Si-Bone Inc For: 11 October By Investing.com - Investing.com Nigeria
Form 4 Si-Bone Inc For: 6 October By Investing.com - Investing.com Nigeria
Si-Bone SVP Michael Pisetsky sells $56,918 in stock By Investing.com - Investing.com UK
Si-Bone chief op & financial officer sells $94,078 in stock - Investing.com
Si-Bone SVP Michael Pisetsky sells $56,918 in stock - Investing.com
Tax withholding requires SI-BONE (SIBN) legal chief to sell 3,133 shares - Stock Titan
Si-Bone director Jeffrey Dunn sells $369,400 in SIBN shares By Investing.com - Investing.com Nigeria
Si-Bone director Jeffrey Dunn sells $369,400 in SIBN shares - Investing.com
Form 4 Si-Bone Inc For: 5 October By Investing.com - Investing.com UK
After exercising 20,000 options, SI-BONE (SIBN) director Dunn sold 20,000 shares at an average $18.47. - Stock Titan
SI-BONE Officer Anshul Maheshwari Files Form 144 to Sell 1,731 Shares of Common Stock - Kalkine Media
An officer proposes selling 1,731 SI-BONE (NASDAQ: SIBN) shares valued at $31.3K. - Stock Titan
Tax-related sales accompany a 1,731-share trading-plan sale by SI-BONE (SIBN) CFO - Stock Titan
SI-BONE (SIBN) Climbs 2.08% to $19.15, Pressing Toward Upper Range BoundaryMcClellan Summation - https://www.siam.in/
SI-Bone stock gains after FDA clears spinal fusion system By Investing.com - Investing.com South Africa
SI-BONE receives FDA clearance for spinal fusion system By Investing.com - Investing.com South Africa
SI-BONE receives FDA clearance for spinal fusion system - Investing.com India
SI-Bone stock gains after FDA clears spinal fusion system - Investing.com
OrthoPediatrics Corp. (KIDS) Stock Price, News, Quote & History - ca.finance.yahoo.com
SI-BONE at Morgan Stanley conference: growth broadens beyond pelvis By Investing.com - Investing.com India
SI-BONE (NASDAQ: SIBN) Anticipates Up to $150,000 Charge from iFuse TORQ Packaging Recall - Kalkine Media
Understanding the Setup: (SIBN) and Scalable Risk - Stock Traders Daily
SI-BONE Announces Voluntary Recall of iFuse TORQ Implants - TipRanks
SI-BONE Enters Fourth Amendment To Lease On Sept 11, 2026SEC Filing - TradingView
SIBN stock focus on SI-BONE market and fundamentals - ad-hoc-news.de
Si-Bone director Jeffrey Dunn sells $378,160 of common stock By Investing.com - Investing.com South Africa
Si-Bone director Jeffrey Dunn sells $378,160 of common stock - Investing.com
Si-Bone director Jeffrey Dunn sells $378,160 of common stock By Investing.com - Investing.com Canada
Si-Bone director Jeffrey Dunn sells $378,160 of common stock By Investing.com - Investing.com India
Si-Bone director Jeffrey Dunn sells $378,160 of common stock By Investing.com - Investing.com UK
SI-BONE Director Jeffrey Dunn Announces Stock Option Exercises and Sales Under 10b5-1 Plan - Kalkine Media
SI-BONE (SIBN) director exercises options, sells 20K shares - Stock Titan
SIBN Q2 2026 Earnings: 41% EPS Surprise Lifts Shares HigherEarnings Acceleration Picks - vinanet.vn
SI-BONE stock eases below 19 dollars as investors eye recent growth figures - ad-hoc-news.de
SIBN Q2 2026 Earnings: Narrower-Than-Expected Loss Delivers 41% EPS Surprise; Stock Declines 1.18% - dars.gov.et
SI-BONE To Present at Morgan Stanley 24th Global Healthcare Conference on September 14, 2026 - The Manila Times
SI-BONE To Present at Morgan Stanley 24th Global Healthcare Conference on September 14, 2026 - Barchart.com
SI-BONE To Present at Morgan Stanley 24th Global Healthcare Conference on September 14, 2026 - Yahoo Finance
Finanzdaten der Si Bone Inc-Aktie (SIBN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Si Bone Inc-Aktie (SIBN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| DAVID & LAURA FRANCIS JOINT RE | Director |
Oct 12 '26 |
Proposed Sale |
19.37 |
38,006 |
736,176 |
0 |
| ANSHUL MAHESHWARI | Officer |
Oct 05 '26 |
Proposed Sale |
18.08 |
1,731 |
31,296 |
0 |
| Maheshwari Anshul | Chief Op & Financial Officer |
Oct 05 '26 |
Sale |
19.50 |
1,731 |
33,754 |
218,235 |
| PISETSKY MICHAEL A. | SVP, Ops & Adm/Chief Legal Ofr |
Oct 02 '26 |
Sale |
18.17 |
3,133 |
56,918 |
270,517 |
| Maheshwari Anshul | Chief Op & Financial Officer |
Oct 02 '26 |
Sale |
18.18 |
3,318 |
60,325 |
219,966 |
| DUNN JEFFREY W | Director |
Oct 01 '26 |
Sale |
18.47 |
20,000 |
369,400 |
16,057 |
| DUNN JEFFREY W | Director |
Oct 01 '26 |
Option Exercise |
4.68 |
20,000 |
93,600 |
36,057 |
| DUNN JEFFREY W | Director |
Sep 01 '26 |
Sale |
18.91 |
20,000 |
378,160 |
16,057 |
| DUNN JEFFREY W | Director |
Sep 01 '26 |
Option Exercise |
4.68 |
20,000 |
93,600 |
36,057 |
| DAVID & LAURA FRANCIS JOINT RE | Director |
Aug 24 '26 |
Proposed Sale |
19.96 |
25,972 |
518,401 |
0 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):